Monday June 26th 2017

Posts Tagged ‘News’

Medicare Advantage plan members may switch to Original Medicare during the annual disenrollment period Jan 1 to Feb 14

Medicare Advantage plan members may switch to Original Medicare during the annual disenrollment period Jan 1 to Feb 14

Recent changes to the provider networks of certain Medicare Advantage plans (private Medicare managed care plans) are reported to be causing concern within the MS community. Medicare Advantage (MA) plan members are reminded that they have options if they are dissatisfied [Read More]

Lastest Multiple Sclerosis News

Lastest Multiple Sclerosis News

As Genzyme waits for FDA ruling, its multiple sclerosis drug wins approval in … As Cambridge biotech Genzyme awaits an upcoming US regulatory decision on its experimental multiple sclerosis drug, the medicine has won approval for sale in Canada. Genzyme said Friday [Read More]

New Studies Look at Lifestyle Factors in Terms of Who Gets MS and Improving the Daily Lives of People with MS

New Studies Look at Lifestyle Factors in Terms of Who Gets MS and Improving the Daily Lives of People with MS

One of the National Multiple Sclerosis Society’s priorities is to drive research on wellness and lifestyle, where advancements can change quality of life with MS on a daily basis. [Read More]

 Page 1 of 2  1  2 »

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]